Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 427

1.

Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.

Bar-Ad V, Leiby B, Witek M, Xiao Y, Cui Y, Dai Y, Cao J, Axelrod R, Campling B, Both S, Werner-Wasik M.

Am J Clin Oncol. 2014 Oct;37(5):433-7. doi: 10.1097/COC.0b013e31827de7a2.

PMID:
23388558
2.
3.

Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.

Takeda K, Nemoto K, Saito H, Ogawa Y, Takai Y, Yamada S.

Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):626-9.

PMID:
15936536
4.
5.

Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.

Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):100-7. Epub 2006 Jul 12.

PMID:
16839700
6.

Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.

Bradley J, Deasy JO, Bentzen S, El-Naqa I.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1106-13.

PMID:
15001251
7.

Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.

Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1106-12.

PMID:
15519781
8.

Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.

Kim TH, Cho KH, Pyo HR, Lee JS, Han JY, Zo JI, Lee JM, Hong EK, Choi IJ, Park SY, Shin KH, Kim DY, Kim JY.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):995-1002.

PMID:
15990000
9.

Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.

Zhang ZC, Xu J, Li BS, Zhou T, Lu J, Wang ZT, Li HS, Sun HF, Zhu J, Yu JM.

Am J Clin Oncol. 2010 Jun;33(3):271-5. doi: 10.1097/COC.0b013e3181a879e0.

PMID:
19823071
10.

Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.

Rodríguez N, Algara M, Foro P, Lacruz M, Reig A, Membrive I, Lozano J, López JL, Quera J, Fernández-Velilla E, Sanz X.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):810-7. doi: 10.1016/j.ijrobp.2008.04.064. Epub 2008 Aug 26.

PMID:
18755556
11.

Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy.

Zhang Z, Xu J, Zhou T, Yi Y, Li H, Sun H, Huang W, Wang D, Li B, Ying G.

Radiat Oncol. 2014 Feb 15;9:54. doi: 10.1186/1748-717X-9-54.

12.

Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.

Song CH, Pyo H, Moon SH, Kim TH, Kim DW, Cho KH.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):651-8. doi: 10.1016/j.ijrobp.2009.08.068. Epub 2010 Mar 6.

PMID:
20207499
13.

Clinical and dosimetric predictors of radiation-induced esophageal toxicity.

Maguire PD, Sibley GS, Zhou SM, Jamieson TA, Light KL, Antoine PA, Herndon JE 2nd, Anscher MS, Marks LB.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):97-103.

PMID:
10477012
14.

Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.

Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Lebesque J.

Radiother Oncol. 2005 May;75(2):157-64.

PMID:
15890421
15.

Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.

Watkins JM, Wahlquist AE, Shirai K, Garrett-Mayer E, Aguero EG, Fortney JA, Sherman CA, Sharma AK.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1108-13. doi: 10.1016/j.ijrobp.2008.09.013. Epub 2008 Dec 10.

PMID:
19084345
16.
17.

Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).

Zehentmayr F, Söhn M, Exeli AK, Wurstbauer K, Tröller A, Deutschmann H, Fastner G, Fussl C, Steininger P, Kranzinger M, Belka C, Studnicka M, Sedlmayer F.

Radiat Oncol. 2015 May 28;10:121. doi: 10.1186/s13014-015-0429-1.

18.
19.

Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.

Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):318-28.

PMID:
15667949
20.

A Contralateral Esophagus-Sparing Technique to Limit Severe Esophagitis Associated With Concurrent High-Dose Radiation and Chemotherapy in Patients With Thoracic Malignancies.

Al-Halabi H, Paetzold P, Sharp GC, Olsen C, Willers H.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):803-10. doi: 10.1016/j.ijrobp.2015.03.018. Epub 2015 Mar 25.

PMID:
26104934

Supplemental Content

Support Center